Literature DB >> 32526056

Benralizumab rapidly improves asthma control in Austrian real-life severe eosinophilic asthmatics.

Andreas Renner1, Katharina Marth1, Karin Patocka1, Marco Idzko2, Wolfgang Pohl1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32526056     DOI: 10.1111/all.14441

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


× No keyword cloud information.
  1 in total

1.  ChAracterization of ItaliaN severe uncontrolled Asthmatic patieNts Key features when receiving Benralizumab in a real-life setting: the observational rEtrospective ANANKE study.

Authors:  Francesco Menzella; Elena Bargagli; Maria Aliani; Pietro Bracciale; Luisa Brussino; Maria Filomena Caiaffa; Cristiano Caruso; Stefano Centanni; Maria D'Amato; Stefano Del Giacco; Fausto De Michele; Fabiano Di Marco; Elide Anna Pastorello; Girolamo Pelaia; Paola Rogliani; Micaela Romagnoli; Pietro Schino; Gianenrico Senna; Alessandra Vultaggio; Lucia Simoni; Alessandra Ori; Silvia Boarino; Gianfranco Vitiello; Elena Altieri; Giorgio Walter Canonica
Journal:  Respir Res       Date:  2022-02-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.